CN1907321B - 一种治疗表虚不固的药物组合物及其制备工艺 - Google Patents
一种治疗表虚不固的药物组合物及其制备工艺 Download PDFInfo
- Publication number
- CN1907321B CN1907321B CN2006101042806A CN200610104280A CN1907321B CN 1907321 B CN1907321 B CN 1907321B CN 2006101042806 A CN2006101042806 A CN 2006101042806A CN 200610104280 A CN200610104280 A CN 200610104280A CN 1907321 B CN1907321 B CN 1907321B
- Authority
- CN
- China
- Prior art keywords
- solution
- water
- add
- methanol
- reference substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000007812 deficiency Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims description 56
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 95
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 94
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 82
- 238000000034 method Methods 0.000 claims abstract description 46
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 30
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 30
- 239000000661 sodium alginate Substances 0.000 claims abstract description 30
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 25
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 25
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 25
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 25
- 238000003756 stirring Methods 0.000 claims abstract description 24
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 21
- 229930006000 Sucrose Natural products 0.000 claims abstract description 21
- 238000001914 filtration Methods 0.000 claims abstract description 16
- 238000010438 heat treatment Methods 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 237
- 239000000243 solution Substances 0.000 claims description 149
- 238000012360 testing method Methods 0.000 claims description 124
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 74
- 239000007788 liquid Substances 0.000 claims description 66
- 239000000706 filtrate Substances 0.000 claims description 61
- 239000000499 gel Substances 0.000 claims description 58
- 239000013558 reference substance Substances 0.000 claims description 58
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 claims description 49
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 claims description 49
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 47
- 239000000341 volatile oil Substances 0.000 claims description 43
- 239000008194 pharmaceutical composition Substances 0.000 claims description 40
- 239000000284 extract Substances 0.000 claims description 39
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 32
- 239000009636 Huang Qi Substances 0.000 claims description 30
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 30
- 238000005303 weighing Methods 0.000 claims description 30
- 238000004821 distillation Methods 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 24
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 22
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 22
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 22
- 239000007864 aqueous solution Substances 0.000 claims description 21
- 238000003556 assay Methods 0.000 claims description 21
- 239000005720 sucrose Substances 0.000 claims description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 239000000796 flavoring agent Substances 0.000 claims description 18
- 235000019634 flavors Nutrition 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 17
- 239000000945 filler Substances 0.000 claims description 16
- 238000009413 insulation Methods 0.000 claims description 16
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 16
- 239000003208 petroleum Substances 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 16
- 239000000377 silicon dioxide Substances 0.000 claims description 16
- 238000004587 chromatography analysis Methods 0.000 claims description 15
- 239000000741 silica gel Substances 0.000 claims description 15
- 229910002027 silica gel Inorganic materials 0.000 claims description 15
- 239000007921 spray Substances 0.000 claims description 15
- 238000010790 dilution Methods 0.000 claims description 14
- 239000012895 dilution Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- 239000012567 medical material Substances 0.000 claims description 13
- 239000012982 microporous membrane Substances 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 11
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 claims description 10
- 238000000889 atomisation Methods 0.000 claims description 9
- 238000000105 evaporative light scattering detection Methods 0.000 claims description 9
- 239000007789 gas Substances 0.000 claims description 9
- 238000004811 liquid chromatography Methods 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- UIFVCPMLQXKEEU-UHFFFAOYSA-N 2,3-dimethylbenzaldehyde Chemical compound CC1=CC=CC(C=O)=C1C UIFVCPMLQXKEEU-UHFFFAOYSA-N 0.000 claims description 8
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 8
- DGFLRNOCLJGHLY-ZDUSSCGKSA-N 5-O-Methylvisamminol Chemical compound O1C(C)=CC(=O)C2=C1C=C1O[C@H](C(C)(C)O)CC1=C2OC DGFLRNOCLJGHLY-ZDUSSCGKSA-N 0.000 claims description 7
- DGFLRNOCLJGHLY-CYBMUJFWSA-N 5-O-methylvisamminol Natural products O(C)c1c2C(=O)C=C(C)Oc2cc2O[C@@H](C(O)(C)C)Cc12 DGFLRNOCLJGHLY-CYBMUJFWSA-N 0.000 claims description 7
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 claims description 7
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 7
- 230000014759 maintenance of location Effects 0.000 claims description 7
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 238000011003 system suitability test Methods 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims 2
- 238000005516 engineering process Methods 0.000 abstract description 12
- 239000006228 supernatant Substances 0.000 abstract description 4
- 238000009835 boiling Methods 0.000 abstract description 3
- 241000229179 Ledebouriella Species 0.000 abstract 3
- 241000132012 Atractylodes Species 0.000 abstract 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 2
- 229940107666 astragalus root Drugs 0.000 abstract 2
- 239000012153 distilled water Substances 0.000 abstract 2
- 238000009924 canning Methods 0.000 abstract 1
- 230000000881 depressing effect Effects 0.000 abstract 1
- 235000013681 dietary sucrose Nutrition 0.000 abstract 1
- 239000002893 slag Substances 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 35
- 238000002474 experimental method Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 8
- 238000001556 precipitation Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000005374 membrane filtration Methods 0.000 description 5
- 230000036565 night sweats Effects 0.000 description 5
- 206010029410 night sweats Diseases 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 241000545442 Radix Species 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 239000010977 jade Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000009571 yupingfeng Substances 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000012850 discrimination method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940021171 curative drug Drugs 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940041672 oral gel Drugs 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101042806A CN1907321B (zh) | 2006-08-09 | 2006-08-09 | 一种治疗表虚不固的药物组合物及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101042806A CN1907321B (zh) | 2006-08-09 | 2006-08-09 | 一种治疗表虚不固的药物组合物及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1907321A CN1907321A (zh) | 2007-02-07 |
CN1907321B true CN1907321B (zh) | 2010-09-15 |
Family
ID=37698658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101042806A Expired - Fee Related CN1907321B (zh) | 2006-08-09 | 2006-08-09 | 一种治疗表虚不固的药物组合物及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1907321B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107315062A (zh) * | 2017-08-01 | 2017-11-03 | 安徽九洲方圆制药有限公司 | 一种白术饮片与麸炒白术饮片及其配方颗粒的鉴别方法 |
CN108020616A (zh) * | 2017-12-14 | 2018-05-11 | 山东齐都药业有限公司 | 五岳抗甲方中黄芪甲苷的含量测定方法 |
CN109655572A (zh) * | 2019-02-28 | 2019-04-19 | 广东省第二中医院(广东省中医药工程技术研究院) | 一种快速鉴别玉屏风颗粒成分的薄层色谱分析方法 |
-
2006
- 2006-08-09 CN CN2006101042806A patent/CN1907321B/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
国家药典委员会.玉屏风口服液.中华人民共和国药典2005年版一部.化学工业出版社,2005,409. * |
Also Published As
Publication number | Publication date |
---|---|
CN1907321A (zh) | 2007-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105056092B (zh) | 一种参苓白术颗粒的制备方法及其制备的参苓白术颗粒 | |
CN101396544B (zh) | 宣肺平喘的中药组合物及其制备方法 | |
CN101095745B (zh) | 一种归脾颗粒及其制备方法 | |
CN105259295B (zh) | 参枝苓口服液的质量检测方法 | |
CN102274477B (zh) | 一种无糖型风寒感冒颗粒剂制备方法 | |
CN102657823A (zh) | 一种具有抗癌作用的中药组合物及其制备方法和检测方法 | |
CN100400075C (zh) | 一种补气养血药物组合物及其制备方法 | |
CN100525809C (zh) | 由黄芪、红景天和菝葜制成的药物组合物及其制备方法 | |
CN102120015A (zh) | 一种用于舒肝解郁、安神定志的中药及制法和质量标准 | |
CN101773561B (zh) | 一种具有补肾、活血、止痛的中药组合物及其制备方法 | |
CN101496870B (zh) | 一种止咳化痰的中药组合物的检测方法 | |
CN104116963B (zh) | 一种用于抗氧化延缓衰老的五指毛桃复方制剂及其制备方法 | |
CN1907321B (zh) | 一种治疗表虚不固的药物组合物及其制备工艺 | |
CN1907481B (zh) | 一种治疗暑湿感冒的药物组合物及其制备工艺 | |
CN107412658A (zh) | 茯苓薏苡仁中药组合物及其质量控制方法 | |
CN102488837A (zh) | 治疗慢性疲劳综合症的无糖颗粒剂及其制备方法和检测方法 | |
CN102305839A (zh) | 宣肺平喘的中药组合物的检测方法 | |
CN1895451B (zh) | 一种治疗荨麻疹、湿疹的药物组合物及其制备工艺 | |
CN100493579C (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN107102093B (zh) | 复方丹茵膏的检测方法 | |
CN1907436B (zh) | 一种治疗小儿厌食的药物组合物及其制备工艺 | |
CN101406542B (zh) | 一种用于止嗽定喘祛痰的中药口服制剂 | |
CN101011533A (zh) | 一种治疗肾阳虚的中药组合物及其制备方法和质量控制方法 | |
CN114689774A (zh) | 一种当归补血汤标准煎液的制备工艺及其质量控制方法 | |
CN102288701A (zh) | 宣肺平喘的中药组合物的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: MAANSHAN FENGYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: XU XINSHENG Effective date: 20110318 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100012 SCIENTIFIC RESEARCH BUILDING, AREA 4, YARD 5, BEIYUAN, OUTER ANDINGMEN, CHAOYANG DISTRICT, BEIJING TO: 243000 NO. 1503, MEISHAN ROAD, MAANSHAN ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, MAANSHAN CITY, ANHUI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110318 Address after: 243000, No. 1503, Mei Shan Road, Ma'anshan economic and Technological Development Zone, Ma'anshan, Anhui Patentee after: Maanshan Fengyuan Pharmaceutical Co.,Ltd. Address before: 100012 Beijing city Chaoyang District Beiyuan No. five hospital district four scientific research building Patentee before: Xu Xinsheng |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100915 Termination date: 20170809 |